ELEV•benzinga•
Citizens Capital Markets Downgrades Elevation Oncology to Market Perform, Maintains Price Target to $7
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 21, 2025 by benzinga